• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模板的上尿路上皮癌淋巴结切除术:对患者生存的影响。

Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival.

机构信息

Department of Urology, Tokyo Women's Medical University, Medical Center East, Shinjuku-ku, Tokyo, Japan.

出版信息

Int J Urol. 2010 Oct;17(10):848-54. doi: 10.1111/j.1442-2042.2010.02610.x. Epub 2010 Aug 31.

DOI:10.1111/j.1442-2042.2010.02610.x
PMID:20812922
Abstract

OBJECTIVES

The benefit of lymphadenectomy (LND) in patients with urothelial carcinoma of the upper urinary tract (UCUUT) has remained controversial. The aim of this study was to examine the influence of the LND template and the total number of lymph nodes (LN) when increasing the number of patients undergoing complete dissection of regional nodes (CompLND).

METHODS

A total of 109 UCUUT patients with clinically negative nodes underwent nephroureterectomy with concomitant lymphadenectomy at our center. Patients' survival was examined according to the type of LND and the number of removed LN. Univariate analysis was performed to find the cut-off value of LN influencing survival.

RESULTS

Seventy-eight patients underwent CompLND. Incomplete lymphadenectomy was performed in an additional 41 patients. In the patients with pT2 or higher who were clinically negative for nodal metastasis, any cut-off value for the total number of LN removed showed no statistical significance. In contrast, CompLND had a significant impact on patient survival. The Cox proportional hazard model showed that CompLND was a significant factor after adjusting for adjuvant chemotherapy. The total number of removed LN was not significant.

CONCLUSIONS

In patients with muscle-invasive clinical node-negative UCUUT, the number of LN removed shows minimal influence on their survival. In contrast, the influence of the particular type of lymphadenectomy is statistically significant. These findings suggest that the extent of lymphadenectomy should be determined by the template and not by the number of removed LN.

摘要

目的

在上尿路尿路上皮癌(UCUUT)患者中,淋巴结切除术(LND)的获益仍存在争议。本研究旨在探讨当增加完全区域淋巴结清扫术(CompLND)患者数量时,LND 模板和淋巴结总数(LN)的影响。

方法

在我们中心,共对 109 例临床淋巴结阴性的 UCUUT 患者进行了肾输尿管切除术伴同期淋巴结切除术。根据 LND 类型和切除的 LN 数量检查患者的生存情况。采用单因素分析找到影响生存的 LN 切除数量的截止值。

结果

78 例患者行 CompLND,另有 41 例患者行不完全淋巴结切除术。对于临床无淋巴结转移的 pT2 或更高分期的患者,任何切除的 LN 总数的截止值均无统计学意义。相比之下,CompLND 对患者生存有显著影响。Cox 比例风险模型显示,在调整辅助化疗后,CompLND 是一个显著的因素。切除的 LN 总数无显著影响。

结论

对于肌肉浸润性临床淋巴结阴性 UCUUT 患者,切除的 LN 数量对其生存影响最小。相比之下,特定类型的淋巴结切除术的影响具有统计学意义。这些发现表明,淋巴结清扫术的范围应由模板决定,而不是由切除的 LN 数量决定。

相似文献

1
Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival.基于模板的上尿路上皮癌淋巴结切除术:对患者生存的影响。
Int J Urol. 2010 Oct;17(10):848-54. doi: 10.1111/j.1442-2042.2010.02610.x. Epub 2010 Aug 31.
2
Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.区域淋巴结清扫范围对上尿路尿路上皮癌患者生存的影响。
J Urol. 2007 Oct;178(4 Pt 1):1212-7; discussion 1217. doi: 10.1016/j.juro.2007.05.158. Epub 2007 Aug 14.
3
Lymphadenectomy for renal cell carcinoma and urothelial carcinoma of the upper urinary tract: analysis of evidence in the minimally invasive era.肾细胞癌和上尿路尿路上皮癌的淋巴结切除术:微创时代的证据分析。
Minerva Med. 2013 Jun;104(3):261-72.
4
Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.淋巴结清扫术在上尿路尿路上皮癌治疗中的作用:多机构复发分析及阴性淋巴结的免疫组化再评估。
Eur J Surg Oncol. 2010 Nov;36(11):1085-91. doi: 10.1016/j.ejso.2010.08.134. Epub 2010 Sep 15.
5
The emerging role of lymphadenectomy in upper tract urothelial carcinoma.淋巴结切除术在上尿路尿路上皮癌中的新作用。
Urol Clin North Am. 2011 Nov;38(4):429-37, vi. doi: 10.1016/j.ucl.2011.07.012. Epub 2011 Sep 21.
6
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.肿瘤坏死是上尿路上皮癌患者侵袭性生物学行为的一个指标。
Eur Urol. 2010 Apr;57(4):575-81. doi: 10.1016/j.eururo.2009.11.035. Epub 2009 Nov 25.
7
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.淋巴结清扫术对接受根治性肾输尿管切除术治疗的上尿路尿路上皮癌患者癌症特异性生存的影响。
J Urol. 2009 Jun;181(6):2482-9. doi: 10.1016/j.juro.2009.02.021. Epub 2009 Apr 16.
8
Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study.基于模板的肾盂尿路上皮癌淋巴结清扫术:一项前瞻性研究。
Int J Urol. 2014 May;21(5):453-9. doi: 10.1111/iju.12417.
9
Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.上尿路尿路上皮癌的原发部位及淋巴结转移发生率
Urology. 2007 Feb;69(2):265-9. doi: 10.1016/j.urology.2006.10.014.
10
Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.上尿路尿路上皮癌腹腔镜肾输尿管切除术中根据原发肿瘤位置进行区域淋巴结清扫的结果:一项前瞻性研究
J Endourol. 2015 Mar;29(3):304-9. doi: 10.1089/end.2014.0369. Epub 2014 Nov 4.

引用本文的文献

1
Adjuvant Nivolumab Therapy for Upper Tract Urothelial Carcinoma: A Single-Institution Study.辅助性纳武单抗治疗上尿路尿路上皮癌:一项单机构研究
Cureus. 2025 Aug 12;17(8):e89897. doi: 10.7759/cureus.89897. eCollection 2025 Aug.
2
Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).上尿路尿路上皮癌的淋巴结清扫术:临床见解与争议(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8970. Epub 2025 Aug 14.
3
Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular and Upper Tract Urothelial Cancer-Surgical Technique and Outcomes of a Single-surgeon Series.
机器人辅助腹腔镜腹膜后淋巴结清扫术治疗睾丸及上尿路尿路上皮癌——单术者系列的手术技术与结果
Eur Urol Open Sci. 2025 Apr 15;75:120-132. doi: 10.1016/j.euros.2025.03.015. eCollection 2025 May.
4
Preoperative Computed Tomography-Based Prediction and Patterns of Lymph Node Metastasis in Renal Pelvis and Ureteral Urothelial Carcinomas.基于术前计算机断层扫描的肾盂和输尿管尿路上皮癌淋巴结转移预测及模式
Cancers (Basel). 2025 Mar 31;17(7):1180. doi: 10.3390/cancers17071180.
5
The advanced lung cancer inflammation index as a useful prognostic indicator for patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma.晚期肺癌炎症指数作为接受上尿路尿路上皮癌根治性肾输尿管切除术患者的有用预后指标。
World J Urol. 2025 Feb 20;43(1):132. doi: 10.1007/s00345-025-05505-8.
6
Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori.机器人辅助根治性肾输尿管切除术治疗上尿路肿瘤:新型手术机器人系统“日之鸟”的初步应用经验
Transl Cancer Res. 2023 Dec 31;12(12):3522-3529. doi: 10.21037/tcr-23-853. Epub 2023 Dec 21.
7
Mining and validation of prognosis of various visceral metastasis in renal cell carcinoma: a study based on SEER database.肾细胞癌各种内脏转移预后的挖掘与验证:一项基于SEER数据库的研究
Updates Surg. 2024 Apr;76(2):657-676. doi: 10.1007/s13304-023-01703-4. Epub 2024 Jan 2.
8
The Role of Lymph Node Dissection in the Management of Upper Urothelial Cancer: A Nodal Status-Based Meta-Analytical Study.淋巴结清扫在上尿路上皮癌治疗中的作用:一项基于淋巴结状态的Meta分析研究
Urol Res Pract. 2023 Nov;49(6):345-359. doi: 10.5152/tud.2023.23045.
9
Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives.上尿路尿路上皮癌的淋巴结清扫术:现状与未来展望。
Curr Oncol Rep. 2023 Nov;25(11):1327-1344. doi: 10.1007/s11912-023-01460-y. Epub 2023 Oct 6.
10
First Comparison of Retroperitoneal Versus Transperitoneal Robot-Assisted Nephroureterectomy with Bladder Cuff: A Single Center Study.后腹腔与腹腔内机器人辅助肾输尿管切除术与膀胱袖口的首次比较:单中心研究。
Ann Surg Oncol. 2023 Jul;30(7):4531-4539. doi: 10.1245/s10434-023-13363-0. Epub 2023 Apr 26.